175 related articles for article (PubMed ID: 12857552)
1. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.
Aricò M; Boccalatte MF; Silvestri D; Barisone E; Messina C; Chiesa R; Santoro N; Tamaro P; Lippi A; Gallisai D; Basso G; De Rossi G;
Haematologica; 2003 Jul; 88(7):747-53. PubMed ID: 12857552
[TBL] [Abstract][Full Text] [Related]
2. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.
Niinimäki RA; Harila-Saari AH; Jartti AE; Seuri RM; Riikonen PV; Pääkkö EL; Möttönen MI; Lanning M
J Clin Oncol; 2007 Apr; 25(12):1498-504. PubMed ID: 17442991
[TBL] [Abstract][Full Text] [Related]
3. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 95.
Bürger B; Beier R; Zimmermann M; Beck JD; Reiter A; Schrappe M
Pediatr Blood Cancer; 2005 Mar; 44(3):220-5. PubMed ID: 15514916
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or non-Hodgkin-lymphoma treated with hyperbaric-oxygen-therapy (HBO): an approach to cure? -- BME/AON and hyperbaric oxygen therapy as a treatment modality.
Bernbeck B; Christaras A; Krauth K; Lentrodt S; Strelow H; Schaper J; Janssen G; Mödder U; Göbel U
Klin Padiatr; 2004; 216(6):370-8. PubMed ID: 15565553
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin.
Belgaumi AF; Al-Bakrah M; Al-Mahr M; Al-Jefri A; Al-Musa A; Saleh M; Salim MF; Osman M; Osman L; El-Solh H
Cancer; 2003 Jun; 97(11):2898-903. PubMed ID: 12767105
[TBL] [Abstract][Full Text] [Related]
6. Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia.
te Winkel ML; Appel IM; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2008 Oct; 93(10):1570-4. PubMed ID: 18698082
[TBL] [Abstract][Full Text] [Related]
7. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
Mattano LA; Sather HN; Trigg ME; Nachman JB
J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
[TBL] [Abstract][Full Text] [Related]
9. Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
Sawicka-Zukowska M; Kajdas L; Muszynska-Roslan K; Krawczuk-Rybak M; Sonta-Jakimczyk D; Szczepanski T
Pediatr Hematol Oncol; 2006 Dec; 23(8):625-9. PubMed ID: 17065138
[TBL] [Abstract][Full Text] [Related]
10. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database.
Högler W; Wehl G; van Staa T; Meister B; Klein-Franke A; Kropshofer G
Pediatr Blood Cancer; 2007 Jan; 48(1):21-7. PubMed ID: 16317756
[TBL] [Abstract][Full Text] [Related]
11. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
Hurwitz CA; Silverman LB; Schorin MA; Clavell LA; Dalton VK; Glick KM; Gelber RD; Sallan SE
Cancer; 2000 Apr; 88(8):1964-9. PubMed ID: 10760775
[TBL] [Abstract][Full Text] [Related]
12. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase gene polymorphism and glucocorticoid intake in children with ALL and aseptic osteonecrosis.
Bernbeck B; Mauz-Körholz C; Zotz RB; Göbel U
Klin Padiatr; 2003; 215(6):327-31. PubMed ID: 14677097
[TBL] [Abstract][Full Text] [Related]
14. [MRI of aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukemia].
Engelbrecht V; Scherer A; Bruder M; Körholz D; Mödder U
Rofo; 2000 Apr; 172(4):336-41. PubMed ID: 10961217
[TBL] [Abstract][Full Text] [Related]
15. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
Den Boer ML; Harms DO; Pieters R; Kazemier KM; Gobel U; Körholz D; Graubner U; Haas RJ; Jorch N; Spaar HJ; Kaspers GJ; Kamps WA; Van der Does-Van den Berg A; Van Wering ER; Veerman AJ; Janka-Schaub GE
J Clin Oncol; 2003 Sep; 21(17):3262-8. PubMed ID: 12947061
[TBL] [Abstract][Full Text] [Related]
16. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
17. [Osteonecroses of the bilateral tali during maintenance therapy in a child with acute lymphoblastic leukemia].
Nozaki H; Matsubara K; Mori S
Rinsho Ketsueki; 2006 Feb; 47(2):106-10. PubMed ID: 16529012
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia.
Ziino O; Russo D; Orlando MA; Benigno V; Locatelli F; Aricò M
Med Pediatr Oncol; 2002 Jul; 39(1):32-4. PubMed ID: 12116076
[TBL] [Abstract][Full Text] [Related]
19. Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood.
Borgmann A; Zinn C; Hartmann R; Herold R; Kaatsch P; Escherich G; Möricke A; Henze G; von Stackelberg A;
Eur J Cancer; 2008 Jan; 44(2):257-68. PubMed ID: 17981026
[TBL] [Abstract][Full Text] [Related]
20. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.
Schrauder A; Reiter A; Gadner H; Niethammer D; Klingebiel T; Kremens B; Peters C; Ebell W; Zimmermann M; Niggli F; Ludwig WD; Riehm H; Welte K; Schrappe M
J Clin Oncol; 2006 Dec; 24(36):5742-9. PubMed ID: 17179108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
